NCT04753203 2023-10-31
ALCAP
Korean Cancer Study Group
Phase 1/2 Unknown
Clinical Trials
4 trialsNCT02379247 2022-06-07
BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer
University of Kansas Medical Center
Phase 1/2 Completed
NCT04526470 2021-08-24
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
Seoul National University Bundang Hospital
Phase 1/2 Unknown
NCT02298595 2017-11-13
Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
University of Pittsburgh
Phase 1/2 Withdrawn